pramlintide acetate
pramlintide acetate is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including SymlinPen. Available dosage form: injection.
Drug Details
- Generic Name
- pramlintide acetate
- Brand Names
- SymlinPen
- Application Number
- NDA021332
- Sponsor
- AstraZeneca Pharmaceuticals LP
- NDC Codes
- 2
- Dosage Forms
- INJECTION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- PRAMLINTIDE ACETATE
Indications and Usage
1 INDICATIONS AND USAGE SYMLIN is indicated as an adjunctive treatment in patients with type 1 or type 2 diabetes who use mealtime insulin therapy and who have failed to achieve desired glucose control despite optimal insulin therapy. SYMLIN is an amylin analog indicated for patients with type 1 or type 2 diabetes who use mealtime insulin and have failed to achieve desired glycemic control despite optimal insulin therapy (1) .